Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 523,367 | 447,098 | 487,848 | 396,831 | 329,534 |
| Depreciation Amortization | 370,156 | 260,691 | 195,180 | 135,913 | 130,794 |
| Income taxes - deferred | -236,610 | -88,815 | -225,591 | -41,163 | -68,358 |
| Accounts receivable | -92,326 | -40,132 | 12,278 | -25,603 | -24,841 |
| Accounts payable and accrued liabilities | 4,770 | 17,040 | 214 | 361 | -2,280 |
| Other Working Capital | -154,173 | 21,083 | 26,766 | -20,864 | 1,038 |
| Other Operating Activity | 361,217 | 181,939 | 196,392 | 146,916 | 166,056 |
| Operating Cash Flow | $776,401 | $798,904 | $693,087 | $592,391 | $531,943 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 67,900 | -310,915 | -155,000 | -65,275 | 0 |
| PPE Investments | -25,926 | 27,528 | -28,950 | -9,687 | -35,958 |
| Net Acquisitions | -55,074 | N/A | N/A | -1,502,443 | 33,703 |
| Purchase Sale Intangibles | -142,200 | -111,100 | -85,000 | -173,750 | 0 |
| Other Investing Activity | -142,200 | -111,100 | -85,000 | -173,750 | 0 |
| Investing Cash Flow | $-155,300 | $-394,487 | $-268,950 | $-1,751,155 | $-2,255 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 559,393 | 994,647 | 898,642 |
| Debt Repayment | -33,387 | -25,717 | -886,094 | -178,304 | -1,065,760 |
| Common Stock Issued | 57,831 | 93,337 | 31,824 | 24,174 | 40,523 |
| Common Stock Repurchased | -301,450 | -523,672 | -98,799 | -278,296 | -61,553 |
| Other Financing Activity | -16,739 | -23,078 | -15,435 | -21,234 | -26,175 |
| Financing Cash Flow | $-293,745 | $-479,130 | $-409,111 | $540,987 | $-214,323 |
| Exchange Rate Effect | 366 | -1,700 | 5,046 | -5,045 | -10,622 |
| Beginning Cash Position | 309,622 | 386,035 | 365,963 | 988,785 | 684,042 |
| End Cash Position | 637,344 | 309,622 | 386,035 | 365,963 | 988,785 |
| Net Cash Flow | $327,722 | $-76,413 | $20,072 | $-622,822 | $304,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | 776,401 | 798,904 | 693,087 | 592,391 | 531,943 |
| Capital Expenditure | -40,135 | -20,370 | -28,950 | -9,687 | -35,958 |
| Free Cash Flow | 736,266 | 778,534 | 664,137 | 582,704 | 495,985 |